RNF168 could bind to Erα promoter region and facilitate ERα transcriptional activity, enhance the activity of the ERα signal pathway, and thus promote the proliferation of Erα-positive breast cancer cells [56]. This evidence concerns the gene ESR1 and breast carcinoma.